✦ LIBER ✦

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial

✍ Scribed by Adams, Richard ;Meade, Angela ;Wasan, Harpreet ;Griffiths, Gareth ;Maughan, Tim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent chemotherapy plus either in

✍ Wasan, Harpreet; Meade, Angela M; Adams, Richard; Wilson, Richard; Pugh, Cheryl; 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 442 KB

6006 ORAL Intermittent Chemotherapy (CT)

✍ Wasan, H.; Adams, R.A.; Wilson, R.H.; Pugh, C.A.; Fisher, D.; Madi, A.; Sizer, B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

NICE guidance on cetuximab, bevacizumab,

✍ Fiona Rinaldi; Elisabeth George; Amanda I Adler 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 43 KB

A Phase II Trial of FOLFOX6 and Cetuxima

✍ Ralph V. Boccia; Thomas M. Cosgriff; David L. Headley; Suprith Badarinath; Shake 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 410 KB

Addition of cetuximab to oxaliplatin-bas

✍ Timothy S Maughan; Richard A Adams; Christopher G Smith; Angela M Meade; Matthew 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 364 KB

PCN18 Intermittent Versus Continuous Che

✍ Botrel, T.E.A.; Paladini, L.; Clark, O.; Clark, L.G.O. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB